Skip to main content

Table 1 Patient characteristics

From: Cost-effectiveness of fenofibrate for preventing diabetic complications in Australia

 

Mean

Age

61

Female, %

45.9

BMI

33.6

Duration of diabetes

12.4

Smoker, %

14.7

HbA1c, %

8.4

Systolic blood pressure, mmHg

132

HDL, mmol/L

1.3

LDL, mmol/L

3

Haemoglobin, g/dl

14.4

Heart rate, beats/min

78.6

White blood cell count

7

Estimated glomerular filtration rate, ml/min/1.73m2

74.2

History of atrial fibrillation, %

5.4

History of peripheral vascular disease, %

8.4

History of renal failure, %

4.5

Blindness, %

1.9

Albuminuria (micro or macro), %

26.7

History of Ulcer, %

6.3

History of amputation, %

2.3

History of IHD, %

3.2

History of MI, %

9.5

History of stroke, %

15.1

History of CHF, %

14.3